We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
All-cause mortality in randomized trials of cancer screening.
- Authors
Black, William C; Haggstrom, David A; Welch, H Gilbert
- Abstract
The most widely accepted end point in randomized cancer screening trials is disease-specific mortality. The validity of this end point, however, rests on the assumption that cause of death can be determined accurately. An alternative end point is all-cause mortality, which depends only on the accurate ascertainment of deaths and when they occur. We compared disease-specific and all-cause mortality in published randomized cancer-screening trials to indirectly assess the validity of the disease-specific mortality end point.
- Publication
Journal of the National Cancer Institute, 2002, Vol 94, Issue 3, p167
- ISSN
0027-8874
- Publication type
Journal Article
- DOI
10.1093/jnci/94.3.167